Control of blood pressure and lifestyle-related risk factors in elderly Japanese hypertensive subjects

Hypertension Research

Volumn 23, Issue 5, 2000, Pages 441-449

  Muratani, H ^a   Kimura, Y ^a   Fukiyama, K ^a   Kawano, Y ^a   Fujii, J ^a   Abe, K ^a   Kuwajima, I ^a   Ishii, M ^a   Shiomi, T ^a   Mikami, H ^a   Ibayashi, S ^a   Omae, T ^a  

^a UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

Author keywords

Antihypertensive treatment; Elderly patients; Lifestyle modification; Smoking

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE;

ADULT; AGE; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR EFFECT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DATA ANALYSIS; DIABETES MELLITUS; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; JAPAN; LABORATORY TEST; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; OUTPATIENT DEPARTMENT; PATIENT EDUCATION; PRACTICE GUIDELINE; PROTEINURIA; QRS COMPLEX; RISK FACTOR; SEX RATIO; SMOKING; WORLD HEALTH ORGANIZATION;

EID: 0033799442     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.23.441     Document Type: Article

References (28)

1. Mortality and morbidity results from the European working party on high blood pressure in the elderly trial
2. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the systolic hypertension in the elderly program
3. Medical Research Council trial of treatment of hypertension in older adults: Principle results
4. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
5. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
6. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension
7. Antihypertensive therapy and short-term prognosis of elderly hypertensive patients
8. Blood pressure control in a hypertension clinic
9. Inadequate management of blood pressure in a hypertensive population
10. Blood pressure control in a hypertension hospital clinic
11. Current status of antihypertensive therapy for elderly patients in Japan
12. Comprehensive activities of daily living (ADL) index for the elderly
13. Divergent effects of beta-blocker therapy on self-estimated and objectively scored activities of daily living
14. Factors related to impairment of activities of daily living
15. 1999 World health organization-international society of hypertension guidelines for the management of hypertension
16. Trends in hypertension prevalence, treatment, and control: In a well-defined older population
17. Blood-pressure control in the hypertensive population
18. Blood pressure in Spain. Distribution, awareness, control, and benefits of a reduction in average pressure
19. Blood pressure control assessed by ambulatory, home and casual blood pressure: The Ohasama study
20. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989
21. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group
22. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
23. Mortality after 16 years for participants randomized to the multiple risk factor intervention trial
24. Mortality rates in treated hypertensive men with additional risk factors are high but can be reduced: A randomized intervention study
25. Effects of smoking cessation on blood pressure and heart rate variability in habitual smokers
26. Long-term mortality after 5-years multifactorial primary prevention of cardiovascular diseases in middle-aged men
27. The multi-factor primary prevention trial in Goteborg, Sweden